Skip to Content
AP National Business

Purdue Pharma director grilled on proposed opioid settlement

KTVZ
By
Published 12:00 AM

By GEOFF MULVIHILL
Associated Press

NEW YORK (AP) — Purdue Pharma’s quest to settle thousands of lawsuits over OxyContin’s toll has entered its final phase with the grudging acceptance of most of those who have claims against the company. A confirmation hearing opened in U.S. Bankruptcy Court on Thursday for a deal that removes control of the company from members of the wealthy Sackler family and requires them to contribute $4.5 billion to opioid abatement. While most states have come to support the plan, a lawyer representing Connecticut grilled a company board member over whether states should be able to pursue lawsuits against the Sacklers instead.

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

Related Articles

BE PART OF THE CONVERSATION

KTVZ NewsChannel 21 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content